financetom
Business
financetom
/
Business
/
First Bancorp's Q3 net income up 20%, NIM expands
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
First Bancorp's Q3 net income up 20%, NIM expands
Oct 22, 2025 2:03 PM

Overview

* First Bancorp Q3 net income rises 20% yr/yr to $9.1 mln

* Net interest margin expands to 2.70%, up 38 basis points from Q3 2024

* Company reports $139.5 mln growth in non-maturity deposits

Outlook

* Company did not provide specific guidance for future quarters in press release

Result Drivers

* NET INTEREST MARGIN - Expansion to 2.70% driven by enhanced earning asset yields and reduced funding costs

* DEPOSIT GROWTH - Non-maturity deposits increased by $139.5 mln, replacing higher-cost wholesale deposits

* ASSET QUALITY - Overall asset quality remains favorable with a low ratio of non-performing assets

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 EPS $0.81

Q3 Net $9.08

Income mln

Q3 Basic $0.82

EPS

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Johnson & Johnson Says Combined Talvey-Tecvayli Treatment Showed 'High' Response Rates in Blood Cancer Study
Johnson & Johnson Says Combined Talvey-Tecvayli Treatment Showed 'High' Response Rates in Blood Cancer Study
Sep 27, 2024
09:03 AM EDT, 09/27/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Friday updated results from the investigational phase 1b study assessing the combination of Talvey and Tecvayli showed high response rates in triple-class refractory patients with relapsed or refractory multiple myeloma, including those with extramedullary disease. The overall response rate was 79.5% at data cutoff for patients...
Dropbox Insider Sold Shares Worth $3,655,622, According to a Recent SEC Filing
Dropbox Insider Sold Shares Worth $3,655,622, According to a Recent SEC Filing
Sep 27, 2024
09:25 AM EDT, 09/27/2024 (MT Newswires) -- Andrew Houston, 10% Owner, Director, Chief Executive Officer, around September 24, 2024, sold 146,094 shares in Dropbox ( DBX ) for $3,655,622. Following the Form 4 filing with the SEC, Houston has control over a total of 9,427,838 shares of the company, with 8,266,666 shares held directly and 1,161,172 shares controlled indirectly. SEC...
Canada's Job Market Balance Is Shifting Rapidly, Says BMO
Canada's Job Market Balance Is Shifting Rapidly, Says BMO
Sep 27, 2024
08:43 AM EDT, 09/27/2024 (MT Newswires) -- Little more than two years ago, there were one million vacant jobs in Canada, and there were little more than one million unemployed Canadians, noted Bank of Montreal (BMO). Vacancies have since been sliced in half and the number of unemployed has vaulted to nearly 1.5 million. This has sent the unemployed-to-vacant jobs...
Johnson & Johnson Says Results From Blood Cancer Drug Study Support Further Evaluation
Johnson & Johnson Says Results From Blood Cancer Drug Study Support Further Evaluation
Sep 27, 2024
08:41 AM EDT, 09/27/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Friday that an investigational phase 1 study evaluating the combination of Talvey with Darzalex Faspro and pomalidomide in patients with relapsed or refractory multiple myeloma showed an overall response rate of 82%. The company said the data supports continued investigation of the drug combination. The study...
Copyright 2023-2026 - www.financetom.com All Rights Reserved